Process for the preparation of a nitric oxide donating prostaglandin analogue

The present invention relates to a process for preparing hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester of formula (I). In accordance with the present invention, the compound (I) can b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: COUSIN, JONATHAN, DIKER, KHALID, ALMIRANTE, NICOLETTA, RONSIN, GAEL, GORINS, GILLES, BRUNEAU, AUDREY
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator COUSIN, JONATHAN
DIKER, KHALID
ALMIRANTE, NICOLETTA
RONSIN, GAEL
GORINS, GILLES
BRUNEAU, AUDREY
description The present invention relates to a process for preparing hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester of formula (I). In accordance with the present invention, the compound (I) can be efficiently prepared with high purity by coupling bimatoprost in a boronate protected form with 6-(nitrooxy)hexanoyl chloride and removing the boronate protecting group. The invention also relates to a process for the preparation of 6-(nitrooxy) hexanoic acid having a HPLC purity equal to or greater than 99% and containing an amount of 6-{[6-(nitrooxy)hexanoyl]oxy}hexanoic acid (compound(IXa)) equal to or lower than 0.2%.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202241390A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202241390A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202241390A3</originalsourceid><addsrcrecordid>eNqNyjEKAjEQQNE0FqLeYTyAsGZtLEV2sREsFiyXIZnEQJgJmQge3y08gNUv_lub-6OKI1UIUqG9CEqlghVbEgYJgMCp1eRAPskTeOFlcVyYaMOYkX1iQMYs8U1bswqYlXa_bsx-HKbr7UBFZtKCjpjaPD1tZ-3p2J-7S_-P-QLyGTaQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Process for the preparation of a nitric oxide donating prostaglandin analogue</title><source>esp@cenet</source><creator>COUSIN, JONATHAN ; DIKER, KHALID ; ALMIRANTE, NICOLETTA ; RONSIN, GAEL ; GORINS, GILLES ; BRUNEAU, AUDREY</creator><creatorcontrib>COUSIN, JONATHAN ; DIKER, KHALID ; ALMIRANTE, NICOLETTA ; RONSIN, GAEL ; GORINS, GILLES ; BRUNEAU, AUDREY</creatorcontrib><description>The present invention relates to a process for preparing hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester of formula (I). In accordance with the present invention, the compound (I) can be efficiently prepared with high purity by coupling bimatoprost in a boronate protected form with 6-(nitrooxy)hexanoyl chloride and removing the boronate protecting group. The invention also relates to a process for the preparation of 6-(nitrooxy) hexanoic acid having a HPLC purity equal to or greater than 99% and containing an amount of 6-{[6-(nitrooxy)hexanoyl]oxy}hexanoic acid (compound(IXa)) equal to or lower than 0.2%.</description><language>chi ; eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221101&amp;DB=EPODOC&amp;CC=TW&amp;NR=202241390A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221101&amp;DB=EPODOC&amp;CC=TW&amp;NR=202241390A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>COUSIN, JONATHAN</creatorcontrib><creatorcontrib>DIKER, KHALID</creatorcontrib><creatorcontrib>ALMIRANTE, NICOLETTA</creatorcontrib><creatorcontrib>RONSIN, GAEL</creatorcontrib><creatorcontrib>GORINS, GILLES</creatorcontrib><creatorcontrib>BRUNEAU, AUDREY</creatorcontrib><title>Process for the preparation of a nitric oxide donating prostaglandin analogue</title><description>The present invention relates to a process for preparing hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester of formula (I). In accordance with the present invention, the compound (I) can be efficiently prepared with high purity by coupling bimatoprost in a boronate protected form with 6-(nitrooxy)hexanoyl chloride and removing the boronate protecting group. The invention also relates to a process for the preparation of 6-(nitrooxy) hexanoic acid having a HPLC purity equal to or greater than 99% and containing an amount of 6-{[6-(nitrooxy)hexanoyl]oxy}hexanoic acid (compound(IXa)) equal to or lower than 0.2%.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKAjEQQNE0FqLeYTyAsGZtLEV2sREsFiyXIZnEQJgJmQge3y08gNUv_lub-6OKI1UIUqG9CEqlghVbEgYJgMCp1eRAPskTeOFlcVyYaMOYkX1iQMYs8U1bswqYlXa_bsx-HKbr7UBFZtKCjpjaPD1tZ-3p2J-7S_-P-QLyGTaQ</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>COUSIN, JONATHAN</creator><creator>DIKER, KHALID</creator><creator>ALMIRANTE, NICOLETTA</creator><creator>RONSIN, GAEL</creator><creator>GORINS, GILLES</creator><creator>BRUNEAU, AUDREY</creator><scope>EVB</scope></search><sort><creationdate>20221101</creationdate><title>Process for the preparation of a nitric oxide donating prostaglandin analogue</title><author>COUSIN, JONATHAN ; DIKER, KHALID ; ALMIRANTE, NICOLETTA ; RONSIN, GAEL ; GORINS, GILLES ; BRUNEAU, AUDREY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202241390A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>COUSIN, JONATHAN</creatorcontrib><creatorcontrib>DIKER, KHALID</creatorcontrib><creatorcontrib>ALMIRANTE, NICOLETTA</creatorcontrib><creatorcontrib>RONSIN, GAEL</creatorcontrib><creatorcontrib>GORINS, GILLES</creatorcontrib><creatorcontrib>BRUNEAU, AUDREY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>COUSIN, JONATHAN</au><au>DIKER, KHALID</au><au>ALMIRANTE, NICOLETTA</au><au>RONSIN, GAEL</au><au>GORINS, GILLES</au><au>BRUNEAU, AUDREY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Process for the preparation of a nitric oxide donating prostaglandin analogue</title><date>2022-11-01</date><risdate>2022</risdate><abstract>The present invention relates to a process for preparing hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester of formula (I). In accordance with the present invention, the compound (I) can be efficiently prepared with high purity by coupling bimatoprost in a boronate protected form with 6-(nitrooxy)hexanoyl chloride and removing the boronate protecting group. The invention also relates to a process for the preparation of 6-(nitrooxy) hexanoic acid having a HPLC purity equal to or greater than 99% and containing an amount of 6-{[6-(nitrooxy)hexanoyl]oxy}hexanoic acid (compound(IXa)) equal to or lower than 0.2%.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_TW202241390A
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Process for the preparation of a nitric oxide donating prostaglandin analogue
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T21%3A59%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=COUSIN,%20JONATHAN&rft.date=2022-11-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202241390A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true